What is NDC 71610-770?

71610-770 is the product NDC for Zolpidem Tartrate, Zolpidem tartrate 6.25 mg/1 tablet, film coated, extended release, listed with the FDA by Aphena Pharma Solutions - Tennessee, LLC. It has 5 package NDCs, shown above in 10- and 11-digit form.

Aphena Pharma Solutions - Tennessee, LLC, NDC labeler code 71610. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Zolpidem Tartrate?

116 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Zolpidem Tartrate NDC 71610-770 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71610-770Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71610-0770Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71610-770-15	7161007701571610077015	15 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-770-15)Marketed from Jan 19, 2024
71610-770-28	7161007702871610077028	28 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-770-28)Marketed from Jan 19, 2024
71610-770-30	7161007703071610077030	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-770-30)Marketed from Jan 19, 2024
71610-770-53	7161007705371610077053	60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-770-53)Marketed from Jan 19, 2024
71610-770-60	7161007706071610077060	90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-770-60)Marketed from Jan 19, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Zolpidem Tartrate
Generic name (nonproprietary): zolpidem tartrate
Active ingredients: Zolpidem tartrate — 6.25 mg/1
Dosage form: Tablet, Film coated, Extended release
Route: Oral
Labeler: Aphena Pharma Solutions - Tennessee, LLCNDC labeler code 71610
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 021774
Marketing start: Oct 14, 2010
Listing expires: Dec 31, 2026
DEA schedule: CIV
Other FDA classes: Central Nervous System Depression (Physiologic effect)GABA A Agonists (Mechanism)Pyridines (Chemical structure)
Identifiers: Product ID 71610-770_4602534f-29d4-4797-95d1-479735045513SPL ID 4602534f-29d4-4797-95d1-479735045513SPL set ID 39d91478-ea0e-407e-b5cb-0eeb592e0aa4RxCUI 854894UNII WY6W63843K
Pharmacologic class: gamma-Aminobutyric Acid-ergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471610077015 followed by a unit qualifier and the quantity

Package 71610-0770-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 23, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Zolpidem Tartrate Extended-Release Tablets are indicated for the short-term treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance (as measured by wake time after sleep onset). The clinical trials performed in support of efficacy were up to 3 weeks (using polysomnography measurement up to 2 weeks in both adult and elderly patients) and 24 weeks (using patient-reported assessment in adult patients only) in duration [see Clinical Studies (14) ] . Zolpidem Tartrate Extended-Release Tablets, a gamma-aminobutyric acid (GABA) A receptor positive modulator, is indicated for the short-term treatment of insomnia characterized by difficulties with sleep onset and…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71610-770

What is NDC 71610-770?: 71610-770 is the product NDC for Zolpidem Tartrate, Zolpidem tartrate 6.25 mg/1 tablet, film coated, extended release, listed with the FDA by Aphena Pharma Solutions - Tennessee, LLC. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Zolpidem Tartrate.
What is the active ingredient?: Zolpidem tartrate.
Who is the labeler?: Aphena Pharma Solutions - Tennessee, LLC, NDC labeler code 71610. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Zolpidem Tartrate?: 116 other product NDCs are listed under this name. See all Zolpidem Tartrate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Zolpidem Tartrate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Zolpidem Tartrate	Zolpidem tartrate 7.5 mg/1	CapsuleOral	TORRENT PHARMACEUTICALS LIMITED	13668-775	13668-0775-30
Zolpidem Tartrate	Zolpidem tartrate 6.25 mg/1	Tablet, Extended releaseOral	Breckenridge Pharmaceutical, Inc.	51991-981	51991-0981-01
Zolpidem Tartrate	Zolpidem tartrate 12.5 mg/1	Tablet, Extended releaseOral	Breckenridge Pharmaceutical, Inc.	51991-982	51991-0982-01
Zolpidem Tartrate	Zolpidem tartrate 7.5 mg/1	CapsuleOral	Umedica Laboratories USA Inc.	60290-089	60290-0089-0160290-0089-02
Zolpidem Tartrate	Zolpidem tartrate 10 mg/1	Tablet, CoatedOral	Northwind Health Company, LLC	82868-078	82868-0078-30
Zolpidem Tartrate	Zolpidem tartrate 5 mg/1	Tablet, CoatedOral	Advanced Rx of Tennessee, LLC	80425-0513	80425-0513-0180425-0513-0280425-0513-03
Zolpidem Tartrate	Zolpidem tartrate 5 mg/1	Tablet, CoatedOral	Preferred Pharmaceuticals Inc.	68788-8854	68788-8854-0368788-8854-06
Zolpidem Tartrate	Zolpidem tartrate 5 mg/1	Tablet, Film coatedOral	American Health Packaging	60687-838	60687-0838-01
Zolpidem Tartrate	Zolpidem tartrate 12.5 mg/1	Tablet, Extended releaseOral	St. Mary's Medical Park Pharmacy	60760-819	60760-0819-30
Zolpidem Tartrate	Zolpidem tartrate 5 mg/1	TabletOral	Chartwell RX, LLC	62135-778	62135-0778-90

All 117 Zolpidem Tartrate NDCs

Other NDCs under NDA 021774

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 021774
Product	Strength	Form · route	Labeler	Product NDC
Ambien CRzolpidem tartrate	Zolpidem tartrate 6.25 mg/1	Tablet, CoatedOral	Cosette Pharmaceuticals, Inc.	0713-5501
Ambien CRzolpidem tartrate	Zolpidem tartrate 12.5 mg/1	Tablet, CoatedOral	Cosette Pharmaceuticals, Inc.	0713-5521
zolpidem tartrate	Zolpidem tartrate 6.25 mg/1	Tablet, CoatedOral	Golden State Medical Supply, Inc.	51407-761
zolpidem tartrate	Zolpidem tartrate 12.5 mg/1	Tablet, CoatedOral	Golden State Medical Supply, Inc.	51407-762
Zolpidem Tartrate	Zolpidem tartrate 12.5 mg/1	Tablet, Film coated, Extended releaseOral	Proficient Rx LP	63187-862